EUVIMEDEUVIMED entdecken
Leitlinie

Results of an international survey of opinions on the definitions and treatments for heparin-induced thrombocytopenia: communication from the ISTH SSC Subcommittee on Platelet Immunology

Philip Young-Ill Choi, Günalp Uzun, Tamam Bakchoul, SSC Platelet Immunology of the ISTH

Journal of Thrombosis and Haemostasis · 2024

DOI: 10.1016/j.jtha.2024.01.014 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of Thrombosis and Haemostasis, 2024. Verfasst von Philip Young-Ill Choi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Haematology Department, the Canberra Hospital, Garran, Canberra, Australian Capital Territory, Australia; John Curtin School of Medical Research, Aus…. Hauptthemen laut MEDLINE: Heparin, Immunoglobulins, Intravenous, Thrombocytopenia, Anticoagulants. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: International Society on Thrombosis and Haemostasis.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heparin-induced thrombocytopenia (HIT) is rare, affecting fewer than 1 in 1500 hospital admissions. Despite the increasing adoption of new therapies in HIT, such as direct oral anticoagulants and pooled immunoglobulins, there is limited high-quality evidence to guide clinicians. Numerous uncommon presentations of HIT and HIT-like entities have recently been recognized, and a harmonized approach to their classification is required to study them better. We present the results of an international survey of opinions from experts and practitioners in the field of platelet immunology regarding the role of direct oral anticoagulants in HIT, novel definitions of subclassifications of HIT-like platelet factor 4 immune conditions (spontaneous autoimmune HIT, persistent autoimmune HIT, and treatment-refractory HIT), and the role for intravenous immunoglobulins in the treatment paradigm of HIT and these HIT-like conditions. From 102 survey responses, there was broad acceptance of rivaroxaban (74.5%) and apixaban (73.5%) even before platelet recovery, as well as for intravenous immunoglobulin in the management of spontaneous (85.6%), persistent (83.7%), and treatment-refractory HIT (87.4%). With this mandate for harmonizing terminologies and treatment approaches in special situations without robust clinical data owing to their rarity, we plan to conduct a robust survey, establish international consensus, and draft management guidelines for HIT and platelet factor 4 immune diseases in the near future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HeparinImmunoglobulins, IntravenousThrombocytopeniaAnticoagulantsPlatelet Factor 4HumansSurveys and QuestionnairesPyrazolesBlood PlateletsPyridonesRivaroxabanPurpura, Thrombocytopenic, IdiopathicHealth Care SurveysTerminology as Topic

Stichwörter der Autor:innen

DOACHITautoimmunepersistentrefractoryspontaneous

Substanzen

HeparinImmunoglobulins, IntravenousAnticoagulantsPlatelet Factor 4PyrazolesPyridonesapixabanRivaroxabanPF4 protein, human

Autor:innen und Institutionen

  • Haematology Department, the Canberra Hospital, Garran, Canberra, Australian Capital Territory, Australia; John Curtin School of Medical Research, Australian National University, Acton, Canberra, Australian Capital Terri…
  • Institute for Clinical and Experimental Transfusion Medicine, University Hospital of Tübingen, Tübingen, Germany; Centre for Clinical Transfusion Medicine, Tübingen, Germany.
  • Institute for Clinical and Experimental Transfusion Medicine, University Hospital of Tübingen, Tübingen, Germany; Centre for Clinical Transfusion Medicine, Tübingen, Germany. Electronic address: tamam.bakchoul@med.uni-t…

Förderung

  • International Society on Thrombosis and Haemostasis

Zitieren

APA

Choi, P. Y., Uzun, G., Bakchoul, T., & SSC Platelet Immunology of the ISTH (2024). Results of an international survey of opinions on the definitions and treatments for heparin-induced thrombocytopenia: communication from the ISTH SSC Subcommittee on Platelet Immunology. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2024.01.014

Vancouver

Choi PY, Uzun G, Bakchoul T, SSC Platelet Immunology of the ISTH. Results of an international survey of opinions on the definitions and treatments for heparin-induced thrombocytopenia: communication from the ISTH SSC Subcommittee on Platelet Immunology. Journal of Thrombosis and Haemostasis. 2024. doi:10.1016/j.jtha.2024.01.014

BibTeX
@article{Choi2024,
  author = {Choi, Philip Young-Ill and Uzun, Günalp and Bakchoul, Tamam and SSC Platelet Immunology of the ISTH, SSC Platelet Immunology of the ISTH},
  title = {Results of an international survey of opinions on the definitions and treatments for heparin-induced thrombocytopenia: communication from the ISTH SSC Subcommittee on Platelet Immunology},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2024},
  doi = {10.1016/j.jtha.2024.01.014}
}
Kostenlos starten →